Domov › Rakovina prostaty › Kalifornia › Los Angeles
Klinické štúdie Rakovina prostaty v meste Los Angeles, CA
61 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Los Angeles a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Prebieha náborFáza 2
- Cedars Sinai Medical Center, Los Angeles
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- Research Site, Los Angeles
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
Prebieha náborFáza 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Prebieha náborFáza 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Prebieha náborFáza 3
- Cedars-Sinai Medical Center, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Prebieha náborFáza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Prebieha náborFáza 3
- UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Prebieha náborFáza 1/2
- Research Site, Los Angeles
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prebieha náborFáza 3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center - Drug Information Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
- a 1 ďalších
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- START Los Angeles, Los Angeles
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prebieha náborFáza 2/3
- VA Greater LA Healthcare System, Los Angeles
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prebieha náborFáza 3
- Research Site, Los Angeles
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- Cedars-Sinai Medical Center ( Site 0068), Los Angeles
- UCLA Hematology/Oncology - Santa Monica ( Site 0002), Los Angeles
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prebieha náborFáza 3
- Urology Group of Southern California, Los Angeles
- Greater Los Angeles VA Medical Center, Los Angeles
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Prebieha náborObservačná štúdia
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
Prebieha nábor
- USC / Norris Comprehensive Cancer Center, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Prebieha náborFáza 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Prebieha náborFáza 2
- START Los Angeles, Los Angeles
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
Prebieha náborObservačná štúdia
- University of California at Los Angeles, Los Angeles
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
Prebieha nábor
- University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- University of California, Los Angeles (UCLA), Los Angeles
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Prebieha náborFáza 2
- VA Greater Los Angeles Healthcare System, Los Angeles
- UCLA Clark Urology Center, Los Angeles
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prebieha náborFáza 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Prebieha nábor
- Cedars-Sinai Medical Center, Los Angeles
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
Prebieha náborFáza 2
- Cedars-Sinai Medical Center, Los Angeles
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Prebieha náborFáza 2
- University of California, Los Angeles (Data and Specimen Analysis Only), Los Angeles
PSMA PET Combined With MRI for the Detection of PCa
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- University of California Los Angeles, Los Angeles
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Prebieha náborSkorá fáza 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Prebieha náborFáza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Prebieha náborFáza 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- a 2 ďalších
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Prebieha náborObservačná štúdia
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Prebieha náborFáza 2
- VA Greater Los Angeles Healthcare System, Los Angeles
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Prebieha náborFáza 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Prebieha náborFáza 1
- Start Lacn, Los Angeles
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Prebieha nábor
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Active Surveillance for Cancer of the Prostate (ASCaP)
Prebieha náborObservačná štúdia
- University of California Los Angeles, Los Angeles
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Prebieha nábor
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Prebieha nábor
- UCLA, Los Angeles
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Prebieha náborObservačná štúdia
- University of California, Los Angeles, Los Angeles
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Prebieha náborFáza 1/2
- Charles R. Drew University of Medicine and Science, Los Angeles
Mechanisms of Resistance to PSMA Radioligand Therapy
Prebieha náborObservačná štúdia
- University of California, Los Angeles, Los Angeles
Access to Genetic Testing in Underserved Patients With Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- USC / Norris Comprehensive Cancer Center, Los Angeles
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Prebieha náborFáza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
Prebieha náborFáza 2
- Cedars-Sinai Medical Center, Los Angeles
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Prebieha náborSkorá fáza 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Prebieha náborFáza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Prebieha nábor
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
Prebieha náborFáza 3
- University of California at Los Angeles, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Southern California, Los Angeles
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
Prebieha nábor
- Cedars Sinai Medical Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prebieha náborFáza 3
- Los Angeles County-USC Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Prebieha náborFáza 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Prebieha náborFáza 4
- VA Greater Los Angeles Healthcare System, Los Angeles
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN43 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
- Dallas, TX36 štúdií
Iné štúdie v Los Angeles
- Nemalobunkový karcinóm pľúc87 štúdií
- Rakovina (všetky typy)74 štúdií
- Rakovina prsníka73 štúdií
- Kolorektálny karcinóm59 štúdií
- Metastatická rakovina57 štúdií
- Rakovina vaječníkov50 štúdií
- Rakovina pľúc45 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku42 štúdií
- Rakovina pankreasu35 štúdií
- Rakovina endometria34 štúdií
- Melanóm34 štúdií
- Trojnásobne negatívny karcinóm prsníka27 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.